Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

RenovoRx, Inc.

CIK 1574094Updated Nov 18, 2026

RNXT price & chart

Provider market data

Loading TradingView…

NASDAQ:RNXT on TradingView ↗

TradingView · Data may be delayed

About the company

RenovoRx, Inc. (Nasdaq: RNXT) is a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, U.S. Food and Drug Administration (FDA)-cleared local drug-delivery device, targeting high unmet medical needs. RenovoRx’s patented Trans-Arterial Micro-Perfusion (TAMP™) therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site to bathe the target tumor, while potentially minimizing a therapy’s toxicities versus systemic intravenous therapy. RenovoRx’s novel approach to targeted treatment offers the potential for increased safety, tolerance, and improved efficacy, and its mission is to transform the lives of cancer patients by providing innovative solutions to enable targeted delivery of diagnostic and therapeutic agents.

8-K/A · 2026-08-13 · 0001193125-26-349157

Company description from the cited filing.

Financials

FY 2025 · USD
Revenue1,123,000USD · FY 2025
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

Net income-11,168,000USD · FY 2025
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

Operating income-12,510,000USD · FY 2025
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

Diluted EPS-0.32USD per share · FY 2025
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD11,206,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

10,031,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

11,472,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

13,643,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

12,004,000
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

13,964,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

16,014,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

4,788,000
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

8,095,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

8,118,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

1,466,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

7,265,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Property, Plant and Equipment, NetUSD13,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

—94,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

13,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

—77,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

13,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

—12,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

12,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

——
Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD10,044,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

9,563,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

9,479,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

12,314,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

11,742,000
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

12,362,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

14,582,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

4,389,000
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

7,024,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

7,154,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

1,173,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

4,391,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD169,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

—480,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

363,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

—280,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

242,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

—139,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

43,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

——
Inventory, NetUSD272,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

—383,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

——379,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

——189,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

———
Assets, CurrentUSD10,980,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

—10,810,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

13,395,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

—13,720,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

15,745,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

—7,893,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

7,828,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

—7,265,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD—468,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

——262,000
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

——271,000
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

——192,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

825,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD213,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

—368,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

235,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

—167,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

256,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

—190,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

278,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

——
LIABILITIES AND EQUITY
LiabilitiesUSD3,128,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

2,960,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

2,493,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

3,002,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

2,732,000
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

2,699,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

2,857,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

3,021,000
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

2,673,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

3,640,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

4,466,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

1,102,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD————————0
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

———
Common Stock, Value, IssuedUSD4,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

2,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

5,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

4,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

2,000
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

5,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

4,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

2,000
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

4,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

2,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

1,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

1,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-58,446,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

-47,341,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

-67,819,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

-55,534,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

-44,870,000
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

-64,908,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

-52,639,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

-42,481,000
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

-61,387,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

-50,219,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

-41,405,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

-31,173,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD———————————17,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD8,078,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

7,071,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2024-09-30

8,979,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

10,641,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2025-06-30

9,272,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2024-06-30

11,265,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

13,157,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2025-03-31

1,767,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2024-03-31

5,422,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

4,478,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

-3,000,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

6,163,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Additional Paid in Capital, Common StockUSD66,520,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

—76,793,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

66,171,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

—76,168,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

65,792,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

—66,805,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

54,695,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

38,404,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

37,318,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Liabilities and EquityUSD11,206,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

10,031,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

11,472,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

13,643,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

12,004,000
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

13,964,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

16,014,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

4,788,000
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

8,095,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

8,118,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

1,466,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

7,265,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD1,884,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

1,772,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

1,884,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

1,556,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

1,311,000
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

1,920,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

1,736,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

1,093,000
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

1,962,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

1,909,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

1,175,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

—
Operating Lease, Liability, CurrentUSD102,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

—131,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

99,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

—108,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

97,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

—105,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

66,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

——
Accounts Payable, CurrentUSD869,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

686,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

866,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

671,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

438,000
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

1,119,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

967,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

356,000
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

799,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

586,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

561,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

534,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD134,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

—259,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

161,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

—78,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

186,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

—107,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

212,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

——
Additional Financial Items
Accrued Liabilities, CurrentUSD1,015,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

As of 2025-09-30

1,086,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

1,018,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

885,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

As of 2025-06-30

873,000
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

801,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

As of 2026-03-31

769,000
Source

10-Q · 2025-05-15 · 0001641172-25-010935

As of 2025-03-31

737,000
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

1,163,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

1,323,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

614,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

As of 2023-12-31

568,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD———————————6,400,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Deferred Tax Liabilities, NetUSD————————49,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

As of 2025-12-31

79,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

As of 2024-12-31

—18,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

Other Assets, Noncurrent———
Source

10-Q · 2026-08-13 · 0001193125-26-349190

As of 2026-06-30

—————————
Additional Paid in Capital——
Source

10-Q · 2024-11-13 · 0001493152-24-045137

As of 2024-09-30

———
Source

10-Q · 2024-08-13 · 0001493152-24-031675

As of 2024-06-30

———
Source

10-Q · 2024-05-10 · 0001493152-24-018704

As of 2024-03-31

————

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization———
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

———
Source

10-Q · 2025-08-14 · 0001641172-25-024020

2025-04-01 to 2025-06-30

—
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

——
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
Share-based Payment Arrangement, Noncash ExpenseUSD——349,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

255,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

570,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

345,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

317,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

288,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

1,267,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

1,174,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

1,078,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

644,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in InventoriesUSD——————190,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

189,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
Increase (Decrease) in Accounts PayableUSD——————254,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

381,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

213,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

25,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

27,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

9,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Deferred Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
Net Cash Provided by (Used in) Operating ActivitiesUSD——————-3,709,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

-3,381,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

-10,973,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

-9,125,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

-10,258,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

-8,811,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————0
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

-2,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

-2,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

-12,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

2,032,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

-2,032,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————0
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

2,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

2,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

12,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

——
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————9,047,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

10,811,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

10,845,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

15,118,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

5,008,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

42,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————5,338,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

7,428,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

-130,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

5,981,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

-3,218,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

-10,801,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD——————0
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

5,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

16,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

21,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

——
Income Taxes Paid, NetUSD——————0
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

1,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

1,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

2,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

——
Additional Financial Items
Cash, Cash Equivalents, and Short-term InvestmentsUSD———————————6,400,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

As of 2022-12-31

DepreciationUSD——————1,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

1,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

2,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
General and Administrative ExpenseUSD———1,178,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

2024-07-01 to 2024-09-30

——————5,729,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

5,649,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——————0
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

2,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
Net Income (Loss) Attributable to ParentUSD——-2,912,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

-2,471,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

-2,911,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

-2,895,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

-3,521,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

-2,420,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

-11,168,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

-8,814,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

-10,232,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

-9,889,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——288,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

357,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

438,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

-217,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

-52,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

690,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

1,342,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

2,156,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

1,164,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

61,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Operating ExpensesUSD——3,413,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

2,828,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

4,115,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

2,948,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

3,948,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

3,213,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

13,306,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

11,013,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

11,396,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

9,950,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD———21,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

2024-07-01 to 2024-09-30

——————75,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

72,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD———————————4,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD——————10,000,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

12,102,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

12,102,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

15,016,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

5,000,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

—
Proceeds from Stock Options ExercisedUSD——————0
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

8,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

17,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

69,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

8,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

42,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Increase (Decrease) in Accounts Receivable————————
Source

10-Q · 2025-05-15 · 0001641172-25-010935

2025-01-01 to 2025-03-31

————
Gain (Loss) on Disposition of Assets—————
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

—
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

——————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——266,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

—909,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

422,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

563,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

197,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

1,123,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

43,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

——
Cost of Goods and Services Sold———
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

——
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

—
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

—
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

—
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

—
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
Selling, General and Administrative ExpenseUSD——1,728,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

1,178,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

2,915,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

1,522,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

2,720,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

1,571,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

7,037,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

4,988,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

——
Operating Income (Loss)USD——-3,200,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

-2,828,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

-3,349,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

-2,678,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

-3,469,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

-3,110,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

-12,510,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

-10,970,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

-11,396,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

-9,950,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD———————————4,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD————————-11,167,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
Income Tax Expense (Benefit)USD——————0
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

2,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
Net Income (Loss) Attributable to ParentUSD——-2,912,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

-2,471,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

-2,911,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

-2,895,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

-3,521,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

-2,420,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

-11,168,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

-8,814,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

-10,232,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

-9,889,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.08
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

-0.1
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

-0.06
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

-0.08
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

-0.09
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

-0.08
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

-0.32
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

-0.4
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

-0.99
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

-1.09
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-0.08
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

-0.1
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

-0.06
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

-0.08
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

-0.09
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

-0.08
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

-0.32
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

-0.4
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

-0.99
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

—
Weighted Average Number of Shares Outstanding, Basicshares——36,646,278
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

24,940,746
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

47,298,148
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

36,576,567
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

38,032,421
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

31,395,888
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

35,333,127
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

22,271,163
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

10,290,667
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

9,051,726
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——36,646,278
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

24,940,746
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

47,298,148
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

36,576,567
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

38,032,421
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

31,395,888
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

35,333,127
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

22,271,163
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

10,290,667
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

—
Additional Financial Items
Current Income Tax Expense (Benefit)USD————————2,450,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
Depreciation, Depletion and Amortization, NonproductionUSD——1,000,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

——1,000,000
Source

10-Q · 2025-08-14 · 0001641172-25-024020

2025-04-01 to 2025-06-30

1,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

—2,000,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
General and Administrative ExpenseUSD———1,178,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

2024-07-01 to 2024-09-30

——————5,729,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

5,649,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Gross ProfitUSD——213,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

—766,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

270,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

479,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

103,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

796,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

43,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

——
Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-11,167,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

———
Interest Income (Expense), Nonoperating, NetUSD——113,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

124,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

90,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

133,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

45,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

106,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

427,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

384,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

108,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

57,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——288,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

357,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

438,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

-217,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

-52,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

690,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

1,342,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

2,156,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

1,164,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

61,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Operating ExpensesUSD——3,413,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

2,828,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

4,115,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

2,948,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

3,948,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

3,213,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

13,306,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

11,013,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

11,396,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

9,950,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD———21,000
Source

10-Q · 2024-11-13 · 0001493152-24-045137

2024-07-01 to 2024-09-30

——————75,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

72,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——1,685,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2025-07-01 to 2025-09-30

1,650,000
Source

10-Q · 2025-11-13 · 0001493152-25-022304

2024-07-01 to 2024-09-30

1,200,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2026-04-01 to 2026-06-30

1,426,000
Source

10-Q · 2026-08-13 · 0001193125-26-349190

2025-04-01 to 2025-06-30

1,228,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2026-01-01 to 2026-03-31

1,642,000
Source

10-Q · 2026-05-14 · 0001193125-26-224100

2025-01-01 to 2025-03-31

6,269,000
Source

10-K · 2026-03-30 · 0001193125-26-131928

2025-01-01 to 2025-12-31

6,025,000
Source

10-K · 2025-04-01 · 0001641172-25-001932

2024-01-01 to 2024-12-31

5,667,000
Source

10-K · 2024-04-01 · 0001493152-24-012357

2023-01-01 to 2023-12-31

4,301,000
Source

10-K · 2023-03-31 · 0001493152-23-010332

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-295108

S-3 · 2026-04-16 · 0001493152-26-017111

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

rnxt-ex99_1.htm · 8-K · 2026-11-05

RenovoRx Reports Record Third Quarter 2026 Revenue Exceeding $1 Million Active Commercial Cancer Center Customers Increased to 26 and Total Commercial Funnel Grows to More Than 65 Centers Maintains 2026 Annual Revenue Guidance of $3.75M to $4.25M First Physician-Driven Expansion Using TAMP Beyond Locally Advanced Pancreatic Cancer, Signaling Potential for Broader Clinical Adoption Management to Host Conference Call Today at 4:30 p.m. ET MOUNTAIN VIEW, Calif., November 5, 2026 -- RenovoRx, I…

8-K · 2026-11-05 · 0001193125-26-449890

Read attachment ↗
rnxt-ex99_1.htm · 8-K/A · 2026-08-13

EX-99.1 2 rnxt-ex99_1.htm EX-99.1 EX-99.1 RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth Increases 2026 Annual Revenue Guidance to a Range of $3.75M to $4.25M First Treatment Delivered with RenovoCath® in Patient with Sarcoma in Clinical Setting, Marking Expansion of Device to Other Solid Tumors Phase III TIGeR-PaC Trial Reaches Full Enrollment; Completion of Trial Expected in First Half 2027 wit…

8-K/A · 2026-08-13 · 0001193125-26-349157

Read attachment ↗
rnxt-ex99_1.htm · 8-K · 2026-08-12

EX-99.1 2 rnxt-ex99_1.htm EX-99.1 EX-99.1 RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth Increases 2026 Annual Revenue Guidance to a Range of $3.75M to $4.25M First Treatment Delivered with RenovoCath® in Patient with Sarcoma in Clinical Setting, Marking Expansion of Device to Other Solid Tumors Phase III TIGeR-PaC Trial Reaches Full Enrollment; Completion of Trial Expected in First Half 2027 wit…

8-K · 2026-08-12 · 0001193125-26-346894

Read attachment ↗
ex99-1.htm · 8-K · 2026-08-04

EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 RenovoRx to Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th MOUNTAIN VIEW, Calif., August 4, 2026 - RenovoRx, Inc. (“RenovoRx” or “the Company”) ( Nasdaq: RNXT ), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced it will participate in a JonesTradi…

8-K · 2026-08-04 · 0001493152-26-035995

Read attachment ↗
ex107.htm · S-8 · 2026-06-30

Calculation of Filing Fee Tables S-8 RenovoRx, Inc. ──────────────────────────────────── Table 1: Newly Registered Securities ──────────────────────────────────────── Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee ──────────────────────────────────────────────────…

S-8 · 2026-06-30 · 0001493152-26-031320

Read attachment ↗
rnxt-ex99_1.htm · 8-K · 2026-05-14

EX-99.1 2 rnxt-ex99_1.htm EX-99.1 EX-99.1 RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter Q1 2026 Revenue of $563,000 Totals Over 50% of Full Year 2025 Total Revenue Active Commercial Cancer Center Customers Expand to 16 with Growing Sales Pipeline, Accelerating Adoption of the TAMP™ Therapy Platform Enabled by the RenovoCath® Device Phase III TIGeR-PaC Trial Advances Toward Completion with Full Enrollment Expected in June 2026 Ended First Qu…

8-K · 2026-05-14 · 0001193125-26-224080

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.